Stay updated with breaking news from In Process Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...
Law Offices of Howard G. Smith announces an investigation on behalf of AbbVie Inc. investors concerning the Company’s possible violations of federal securities laws. On April 4, 2024, AbbVie...
Estimated First Quarter 2024 Acquired In-Process Research and Development Charges Eli Lilly and Company currently expects that its reported financial results...
Puma Biotechnology, Inc. , a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2023. Unless otherwise stated, all comparisons are for the...
RVT-3101 demonstrated improved efficacy results from the induction to chronic period in the TUSCANY-2 Phase 2b study in ulcerative colitis and was well...